亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Canine Erythropoietin Gene and Recombinant Protein

詳細技術說明

Anemia, a condition in which too few red blood cells (RBCs) are in circulation is characterized by clinical signs of weakness, lethargy and inappetance and can be divided into two forms - regenerative and nonregenerative

其他

MacLeod JN et al. Expression and bioactivity of recombinant canine erythropoietin. Am J Vet Res. 1998 Sep;59(9):1144-8.

http://www.ncbi.nlm.nih.gov/pubmed/9736393?ordinalpos=18&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Randolph JE et al. Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia. J Vet Intern Med. 2004 Jan-Feb;18(1):81-91.

http://www.ncbi.nlm.nih.gov/pubmed/14765736?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Randolph JF et al. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs. Am J Vet Res. 1999 May;60(5):636-42.

http://www.ncbi.nlm.nih.gov/pubmed/10328437?ordinalpos=17&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

國家/地區

美國

欲了解更多信息，請點擊這裡